Company profile
LiveWire Ergogenics, Inc.
OTC: LVVV · Healthcare · Drug Manufacturers - Specialty & Generic
#990 of 1,418 Healthcare companies by revenuetop-quartile growth
EA Score
——FH —DQ 19GM —SS 33
v0.1 · 25/100 weight · pillars only
↑ revenue growth (YoY), listing tenure · ↓ workforce scale, return on assets
Methodology →Revenue TTM
$60.0k
Rev growth YoY (TTM)
-67.1%
Net income (FY)
-$4.2M
Employees
1
as of 2026-08-26
Market cap
$761.6k
as of 2026-08-26
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$239.0k$239.0k2014
Net income-$4.2M-$4.2M2014
Operating income-$2.9M-$2.9M2014
Total assets$309.6k$309.6k2014
Liabilities$993.6k$993.6k2014
Equity-$683.9k-$683.9k2014
Revenue trend
FY2011 – FY2014 · USD
FY11
FY12
FY13
FY14
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is LiveWire Ergogenics, Inc.’s revenue?
LiveWire Ergogenics, Inc. booked $239.0k in FY2014 revenue, growing 63% year over year — faster than most Healthcare companies we track, at a -1750.7% net margin.
Peers · Healthcare
Bluejay Diagnostics, Inc.33DEnvoy Medical, Inc.33DWellness Center USA, Inc.——Sproutly Canada Inc.——Geron Corporation51DRegen BioPharma, Inc.35DNeighbors
Orange →Key facts
CEOWilliam J. Hodson
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
HeadquartersAnaheim, CA
ExchangeOTC: LVVV
Employees1
IPO date2009-09-08
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.